The ANGPTL7 gene helps make a protein active in the eye, especially in the tissue that drains fluid and helps keep eye pressure balanced. If this gene works differently, that drainage system may behave differently, which can affect pressure inside the eye. Some variants that reduce ANGPTL7 activity are linked to lower eye pressure and a lower chance of glaucoma. Most people with these variants feel no day to day difference.
What is a gene?
A gene is a section of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this subject, you can find more information in the LearnHub.
Overview
ANGPTL7Gene function
What if the gene works
The ANGPTL7 gene helps make a protein active mainly in the eye. It supports tissues linked to fluid flow, which helps maintain normal eye pressure.
Risk
What if the gene does not work
Many ANGPTL7 variants likely change how much protein the ANGPTL7 gene makes or releases. Milder variants may partly alter its effects in the eye's drainage tissue, while more severe variants can more clearly disrupt how nearby cells organize their surrounding support material.
Treatment
What does that mean for your treatment
No ANGPTL7-specific treatment or drug choice is currently established in clinical guidelines. The ANGPTL7 gene is being studied as a drug target for glaucoma, because some loss-of-function variants are linked to lower eye pressure and a lower chance of developing the condition.
Gene function
What if the gene works
In the front of the eye, cells use the ANGPTL7 gene to maintain the material around them. Its protein is released outside cells, where it supports the clear surface and the eye's drainage tissue. This helps these tissues keep their usual structure during normal daily stress.
Cells release the ANGPTL7 protein into the space around them instead of keeping it inside. There, it becomes part of the local tissue environment that helps neighboring cells stay organized.
One of its main roles is to help manage the extracellular matrix (the mesh of proteins around cells). In the clear front surface and the eye's drainage tissue, this supports normal structure and routine tissue maintenance.
ANGPTL7 also influences how cells connect with the material around them. This helps tissues respond to everyday pressure and movement in a more controlled way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic variation. In some situations, however, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ANGPTL7 gene can change how much ANGPTL7 protein is made, whether it keeps its normal shape, and how well it is released from cells. In studies of how ANGPTL7 gene variants affect protein function, some changes seem mild and only partly reduce activity, while more disruptive variants can sharply lower or stop protein production or secretion. These differences can alter the cell surroundings in eye drainage tissue and may influence pressure inside the eye and glaucoma risk.
How variants are linked to conditions
Variants in the ANGPTL7 gene are most clearly associated with eye pressure and glaucoma risk. Large studies have found that some variants in the ANGPTL7 gene are linked to lower intraocular pressure and a lower chance of primary open-angle glaucoma. Research on variants in the ANGPTL7 gene and glaucoma risk shows a population level link, but most variants do not by themselves diagnose an eye condition.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most do not have a direct effect on health and simply represent normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, particularly when several genes and environmental factors both play a role. Still, in some situations, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific day-to-day factors that increase or reduce risk related to the ANGPTL7 gene. Some inherited changes in ANGPTL7 appear to lower the chance of high eye pressure and glaucoma, but these are genetic effects rather than lifestyle-related ones. Anyone concerned about personal eye risk should discuss it with a doctor or genetic counselor.
Inheritance of ANGPTL7 variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific ANGPTL7-related condition, so ANGPTL7 gene inheritance is not described as a standard autosomal dominant, autosomal recessive, or X-linked pattern. Research so far mainly links variants in the ANGPTL7 gene to differences in glaucoma risk rather than to a single inherited syndrome with a settled family pattern. The ANGPTL7 gene is located on chromosome 1, which is an autosome, so you inherit one copy from each parent.
What does my ANGPTL7 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific ANGPTL7-related condition in the way seen with classic single-gene conditions. If you have a specific ANGPTL7 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can help put that finding in family context.
Genetic information
Genetic testing
How you find out about variants
To find changes in the ANGPTL7 gene, a lab can analyze DNA from a blood or saliva sample. This kind of ANGPTL7 genetic testing reads the gene’s code and checks for variants, then the results report whether a change was found and how it is currently classified based on medical evidence.
When should I consider getting a genetic test?
There is not yet a broadly established ANGPTL7-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal or family history of eye disease and are best made with an eye doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you depends on the condition and on the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Part of the difference comes from how the body absorbs, breaks down, transports, or responds to a drug. These inherited differences are common and can influence both how well a medication works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect how people respond to medications. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how powerfully a drug works or how the body handles it. This understanding can support treatment choices that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the ANGPTL7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause. Questions about symptoms, treatment choices, or medication concerns are best discussed with your doctor.
History
The ANGPTL7 gene entered medical research through studies of eye tissue in the early 2000s, when scientists began linking it to pressure control inside the eye. Initially understood only through lab findings, later recognized as tied to inherited differences in glaucoma risk, it drew wider attention as genetic studies became larger. Building on this early work, researchers identified rare ANGPTL7 variants that appeared to lower the chance of developing glaucoma. Findings from large population databases, including major biobank studies, helped confirm that this gene was worth closer study. In recent decades, awareness of this gene’s role has grown mainly within glaucoma research rather than through public media. That shift made ANGPTL7 part of a broader effort to find new ways to understand and treat eye disease.